2007 PH Resource Network Symposium | Pulmonary Hypertension Association Online University

Liver Disease

Swanson KL, Pinson J
Lung Transplant: The Only Definitive Therapy

Horn M, Edelman JD, Szmuszkovicz J, Herrington C
Scleroderma: Common Association, Uncommon Implications

Kingman M, Markin CJ
Methamphetamine & PH: An Emerging Population

Janusz J, Chin K
Free Your Fears of Flolan (Epoprostenol)

Duncan M, Hohsfield R
IV & SQ Remodulin (Treprostinil): Challenges and Solutions

Harris SJ, Liu J, Kitterman N
Inhaled Therapies: The Noninvasive Option

Krichman A, Centeno M
Managing Multiple Oral Therapies

Archer-Chicko C, Schiro AG, Bartlett M
Managing Other Forms of PH: Do Therapies Help these Patients?

Smithson B, Chakinala M, Bartlett M
Chronic Thromboembolic Disease: When Do We Operate?

Kitterman N, Channick R, Auger WR
Changing Tracks: Transitioning From One Therapy to Another

Traiger GL, Frost A
PHA’s Public Policy Agenda and the Importance of Grassroots Advocacy

Dirks D
Conducting Clinical Research

Lawler L, Beckmann J, Park MH
Getting Started: Strategies for Establishing or Expanding a PH Program

Stewart T, Schmidt M, Burger CD
Nurses Exerting an Influence: Certification and Beyond

Petty M